)

SCYNEXIS (SCYX) investor relations material
SCYNEXIS Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Focused on novel antifungal agents, with ibrexafungerp approved for VVC/RVVC and SCY-247 in Phase 1 trials; first new patient dosed in Phase 3 MARIO study after FDA hold lifted, triggering a $10M milestone from GSK, which is disputed.
Transfer of BREXAFEMME NDA to GSK expected by end of 2025 for regulatory relaunch in 2026.
Securities class action lawsuit dismissed with leave to amend; ongoing derivative lawsuits related to manufacturing disclosures.
Received Nasdaq notice for non-compliance with minimum bid price; 180 days to regain compliance.
Financial highlights
Q2 2025 revenue was $1.4M, up 85% year-over-year, mainly from GSK license; six-month revenue was $1.6M, down 23%.
Net loss for Q2 2025 was $6.9M ($0.14 per share), improved from $14.5M ($0.30 per share) in Q2 2024.
Operating expenses for Q2 2025 were $10.9M, up 9.5% year-over-year; R&D expenses rose 5% to $7.1M, SG&A up 20% to $3.8M.
Cash, cash equivalents, and investments totaled $46.5M as of June 30, 2025, down from $75.1M at year-end 2024.
Repayment of $14.0M convertible debt in March 2025.
Outlook and guidance
Cash runway projected into Q4 2026 based on current operating plan.
Anticipates continued significant R&D and SG&A expenses; may require additional capital through equity, debt, or partnerships.
Future capital needs depend on milestone achievements, clinical progress, regulatory outcomes, and collaborations.
Phase 1 SAD/MAD data for SCY-247 expected in Q3 2025.
BREXAFEMME NDA transfer to GSK targeted by end of 2025, with regulatory relaunch discussions planned for 2026.
Next SCYNEXIS earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage